United States · FDA National Drug Code directory
Fluoxetine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50111-648_424ed364-e023-472f-b113-673e9342a7f1
- Product NDC
- 50111-648
- Form
- CAPSULE
- Composition / generic term
- Fluoxetine
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20020129
- Source listing expiry
- 20261231
Source-listed ingredients
- FLUOXETINE HYDROCHLORIDE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (50111-648-01) · 50111-648-01
- 500 CAPSULE in 1 BOTTLE (50111-648-02) · 50111-648-02
- 1000 CAPSULE in 1 BOTTLE (50111-648-03) · 50111-648-03
- 2000 CAPSULE in 1 BOTTLE (50111-648-44) · 50111-648-44
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →